Outcomes Data of Adipose Stem Cells to Treat Osteoarthritis
| Status: | Recruiting |
|---|---|
| Conditions: | Arthritis, Osteoarthritis (OA) |
| Therapuetic Areas: | Rheumatology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/2/2018 |
| Start Date: | September 2014 |
| End Date: | September 2019 |
| Contact: | Holly Bergen |
| Phone: | 800-609-7795 |
Autologous Adipose Stromal Vascular Fraction Outcomes in Osteoarthritis Research Study
The purpose of this study is to determine the impact that treatment with a cellular
concentrate derived from an individual's own fat, known as the stromal vascular fraction
(SVF), has on joint pain and functionality in people with Osteoarthritis (OA). SVF contains
components with "regenerative" properties, including stem cells that have shown promise for
ameliorating specific disease conditions. This study is designed to evaluate joint pain and
functionality changes in individuals with OA for up to 12 months following SVF treatment.
concentrate derived from an individual's own fat, known as the stromal vascular fraction
(SVF), has on joint pain and functionality in people with Osteoarthritis (OA). SVF contains
components with "regenerative" properties, including stem cells that have shown promise for
ameliorating specific disease conditions. This study is designed to evaluate joint pain and
functionality changes in individuals with OA for up to 12 months following SVF treatment.
Inclusion Criteria:
- Fluent in English
- Over the age of 18
- Diagnosed with OA of the knee and/or hip
- Scheduled for intravenous and intra-articular administrations of autologous SVF
- Capable of understanding and willing to sign informed consent
- Willing and able to complete brief phone interviews
- Willing and able to complete online surveys
Exclusion Criteria:
- Co-morbidity with an autoimmune disorder
- Pregnant, may become pregnant, or breastfeeding
- Subjects for which baseline data is not available
We found this trial at
1
site
Click here to add this to my saved trials
